<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD with MathML3 v1.1 20151215//EN" "JATS-journalpublishing1-mathml3.dtd">
<article dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
    <front>
        <journal-meta>
            <journal-id></journal-id> 
            <issn></issn>
        </journal-meta>
        <article-meta>
            <title-group>
                <article-title></article-title>
            </title-group>
            <pub-date>
                <year></year>
            </pub-date>
        </article-meta>
    </front>
    <back>
        <ref-list>
            <ref id="b1">
                <label>1.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Jazbec</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Rajic</surname>
                            <given-names>V</given-names>
                        </name>, 
                        <name>
                            <surname>Karas-Kuzelicki</surname>
                            <given-names>N</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Leukemias of Childhood</article-title>. 
                    <source>Zdrav Vestn</source>.
                    <year>2008</year>
                    <month>Apr</month>;
                    <volume>77</volume>:
                    <fpage>I25</fpage>–
                    <lpage>30</lpage>. 
                    <issn>1318-0347</issn> 
                </mixed-citation>
            </ref>
            <ref id="b2">
                <label>2. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Pui</surname>
                            <given-names>C-H</given-names>
                        </name>, 
                        <name>
                            <surname>Evans</surname>
                            <given-names>WE. A</given-names>
                        </name>
                    </person-group> 
                    <article-title>50-Year Journey to Cure Childhood Acute Lymphoblastic Leukemia<article-title>. 
                    <source>Semin Hematol<source>. 
                    <year>2013</year>
                    <month>Jul</month>; 
                    <volume>Jul</volume>(
                    <issue>Jul</issue>): 
                    <fpage>185</fpage>-
                    <lpage>96<lpage>. 
                    <pub-id pub-id-type="doi">10.1053/j.seminhematol.2013.06.007</pub-id> 
                    <pub-id pub-id-type="pmid">23953334</pub-id 
                    <issn>0037-1963</issn> 
                </mixed-citation>
            </ref>
            <ref id="b3">
                <label>3. </label> 
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Oldenhuis</surname>
                            <given-names>CN</given-names>
                        </name>, 
                        <name>
                            <surname>Oosting</surname>
                            <given-names>SF</given-names>
                        </name>, 
                        <name>
                            <surname>Gietema</surname>
                            <given-names>JA</given-names>
                        </name>, 
                        <name>
                            <surname>de Vries</surname>
                            <given-names>EG</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Prognostic versus predictive value of biomarkers in oncology</article-title>.
                    <source>Eur J Cancer</source>. 
                    <year>2008</year>
                    <month>May</month>;
                    <volume>44</volume>(
                    <issue>7</issue>):
                    <fpage>946</fpage>–
                    <lpage>53</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.ejca.2008.03.006</pub-id> 
                    <pub-id pub-id-type="pmid">18396036</pub-id 
                    <issn>0959-8049</issn> 
                </mixed-citation>
            </ref>
            <ref id="b4">
                <label>4. </label>
                <mixed-citation publication-type="journal>
                    <person-group person-group-type="author">
                        <name>
                            <surname>Friedmann</surname>
                            <given-names>AM</given-names>
                        </name>, 
                        <name>
                            <surname>Weinstein</surname>
                            <given-names>HJ</given-names>
                        </name>
                    </person-group>. 
                    <article-title>The Role of Prognostic Features in the Treatment of Childhood Acute Lymphoblastic Leukemia</article-title>.
                    <source>The Oncologist<source>. 
                    <year>2000</year>
                    <month>Jan</month>;
                    <volume>6</volume>( 
                    <issue>4</issue>):
                    <fpage>321</fpage>-
                    <lpage>8</lpage>. 
                    <pub-id pub-id-type="doi">10.1634/theoncologist.5-4-321</pub-id>
                    <pub-id pub-id-type="pmid">10965000</pub-id 
                    <issn>1083-7159</issn> 
                </mixed-citation> 
            </ref>
            <ref id="b5">
                <label>5. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Burger</surname>
                            <given-names>B</given-names>
                        </name>, 
                        <name>
                            <surname>Zimmermann</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Mann</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Kuhl</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Loning</surname>
                            <given-names>L</given-names>
                        </name>, 
                        <name>
                            <surname>Riehm</surname>
                            <given-names>H</given-names>
                        </name>
                    </person-group>
                    <article-title>Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture</article-title>. 
                    <source>J Clin Oncol</source>. 
                    <year>2003</year>
                    <month>Jan</month>;
                    <volume>21</volume>( 
                    <issue>2</issue>):
                    <fpage>184</fpage>-
                    <lpage>8</lpage>. 
                    <pub-id pub-id-type="doi">10.1200/JCO.2003.04.096</pub-id>
                    <pub-id pub-id-type="pmid">12525508</pub-id 
                    <issn>0732-183X</issn>
                </mixed-citation>
            </ref>
            <ref id="b6">
                <label>6. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Kaspers</surname>
                            <given-names>GJ</given-names>
                        </name>, 
                        <name>
                            <surname>Smets</surname>
                            <given-names>LA</given-names>
                        </name>, 
                        <name>
                            <surname>Pieters</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Van Zantwijk</surname>
                            <given-names>CH</given-names>
                        </name>, 
                        <name>
                            <surname>Van Wering</surname>
                            <given-names>ER</given-names>
                        </name>, 
                        <name>
                            <surname>Veerman</surname>
                            <given-names>AJ</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: results of an in vitro study<article-title>. 
                    <source>Blood</source>. 
                    <year>1995</year>
                    <month>Feb</month>;
                    <volume>85</volume>(
                    <issue>3</issue>: 
                    <fpage>751</fpage>-
                    <lpage>6</lpage>. 
                    <pub-id pub-id-type="pmid">7833478</pub-id 
                    <issn>0006-4971</issn> 
                </mixed-citation> 
            </ref>
            <ref id="b7">
                <label>7. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Loh</surname>
                            <given-names>ML</given-names>
                        </name>, 
                        <name>
                            <surname>Goldwasser</surname>
                            <given-names>MA</given-names>
                        </name>, 
                        <name>
                            <surname>Silverman</surname>
                            <given-names>LB</given-names>
                        </name>, 
                        <name>
                            <surname>Poon</surname>
                            <given-names>WM</given-names>
                        </name>, 
                        <name>
                            <surname>Vattikuti</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Cardoso</surname>
                            <given-names>A</given-names>
                        </name>
                    </person-group>.
                    <article-title>Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01<article-title>. 
                        <source>Blood</source>
                        <year>2006</year>
                        <month>Jun</month>;
                        <volume>107</volume>(
                        <issue>11</issue>): 
                        <fpage>4508</fpage>-
                        <lpage>13</lpage>. 
                        <pub-id pub-id-type="doi">10.1182/blood-2005-08-3451</pub-id>
                        <pub-id pub-id-type="pmid">16493009</pub-id 
                        <issn>0006-4971</issn> 
                </mixed-citation> 
            </ref>
            <ref id="b8">
                <label>8. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Schrappe</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Arico</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Harbott</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Biondi</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Zimmermann</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Conter</surname>
                            <given-names>V</given-names>
                        </name>
                    </person-group>.
                    <article-title>Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome</article-title>. 
                    <source>Blood</source>.
                    <year>1998</year>
                    <month>Oct</month>;
                    <volume>92</volume>(
                    <issue>8</issue>):
                    <fpage>2730</fpage>–
                    <lpage>41</lpage>. 
                    <pub-id pub-id-type="pmid">9763557</pub-id>
                    <issn>0006-4971</issn> 
                </mixed-citation>
            </ref>
            <ref id="b9">
                <label>9. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Johansson</surname>
                            <given-names>B</given-names>
                        </name>, 
                        <name>
                            <surname>Moorman</surname>
                            <given-names>AV</given-names>
                        </name>, 
                        <name>
                            <surname>Haas</surname>
                            <given-names>OA</given-names>
                        </name>, 
                        <name>
                            <surname>Watmore</surname>
                            <given-names>AE</given-names>
                        </name>, 
                        <name>
                            <surname>Cheung</surname>
                            <given-names>KL</given-names>
                        </name>, 
                        <name>
                            <surname>Swanton</surname>
                            <given-names>S</given-names>
                        </name>
                    </person-group>.
                    <article-title>Hematologic malignancies with t(4;11)(q21;q23)--a cytogenetic, morphologic, immunophenotypic and clinical study of 183 cases. European 11q23 Workshop participants<article-title>. 
                    <source>Leukemia</source>.
                    <year>1998</year> 
                    <month>May</month>;
                    <volume>12</volume>(
                    <issue>5</issue>):
                    <fpage>779</fpage>–
                    <lpage>87</lpage>. 
                    <pub-id pub-id-type="doi">10.1038/sj.leu.2401012</pub-id> 
                    <pub-id pub-id-type="pmid">9763557</pub-id> 
                    <issn>0887-6924</issn> 
                </mixed-citation>
            </ref>
            <ref id="b10">
                <label>10. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Crist</surname>
                            <given-names>WM</given-names>
                        </name>, 
                        <name>
                            <surname>Carroll</surname>
                            <given-names>AJ</given-names>
                        </name>, 
                        <name>
                            <surname>Shuster</surname>
                            <given-names>JJ</given-names>
                        </name>, 
                        <name>
                            <surname>Behm</surname>
                            <given-names>FG</given-names>
                        </name>, 
                        <name>
                            <surname>Whitehead</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Vietti</surname>
                            <given-names>TJ</given-names>
                        </name>
                    </person-group>.
                    <article-title>Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group study<article-title>. 
                    <source>Blood</source>
                    <year>1990</year>
                    <month>Jul</month>; 
                    <volume>76</volume>(
                    <issue>1</issue>):
                    <fpage>117</fpage>–
                    <lpage>22</lpage>. 
                    <pub-id pub-id-type="pmid">2364165</pub-id> 
                    <issn>0006-4971</issn> 
                </mixed-citation>
            </ref>
            <ref id="b11">
                <label>11. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Heerema</surname>
                            <given-names>NA</given-names>
                        </name>, 
                        <name>
                            <surname>Carroll</surname>
                            <given-names>AJ</given-names>
                        </name>, 
                        <name>
                            <surname>Devidas</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Loh</surname>
                            <given-names>ML</given-names>
                        </name>, 
                        <name>
                            <surname>Borowitz</surname>
                            <given-names>MJ</given-names>
                        </name>, 
                        <name>
                            <surname>Gastier-Foster</surname>
                            <given-names>JM</given-names>
                        </name>
                    </person-group>.
                    <article-title>Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children’s oncology group studies: a report from the children’s oncology group<article-title>. 
                    <source>J Clin Oncol</source>. 
                    <year>2013</year>.
                    <month>Sep</month>;
                    <volume>31</volume>(
                    <issue>27</issue>):
                    <fpage>3397</fpage>–
                    <lpage>402</lpage>. 
                    <pub-id pub-id-type="doi">10.1200/JCO.2013.49.1308</pub-id>
                    <pub-id pub-id-type="pmid">23940221</pub-id> 
                    <issn>0732-183X</issn> 
                </mixed-citation>
            </ref>
            <ref id="b12">
                <label>12. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Mullighan</surname>
                            <given-names>CG</given-names>
                        </name>, 
                        <name>
                            <surname>Su</surname>
                            <given-names>X</given-names>
                        </name>, 
                        <name>
                            <surname>Zhang</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Radtke</surname>
                            <given-names>I</given-names>
                        </name>, 
                        <name>
                            <surname>Phillips</surname>
                            <given-names>LA</given-names>
                        </name>, 
                        <name>
                            <surname>Miller</surname>
                            <given-names>CB</given-names>
                        </name>
                    </person-group>.
                    <article-title>Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia</article-title>. 
                    <source>N Engl J Med</source>. 
                    <year>2009</year>
                    <month>Jan</month>;
                    <volume>360</volume>(
                    <issue>5</issue>):
                    <fpage>470</fpage>–
                    <lpage>80</lpage>. 
                    <pub-id pub-id-type="doi">10.1056/NEJMc0904548</pub-id>
                    <pub-id pub-id-type="pmid">19387020</pub-id> 
                    <issn>0028-4793</issn> 
                </mixed-citation>
            </ref>
            <ref id="b13">
                <label>13.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Clappier</surname>
                            <given-names>E</given-names>
                        </name>, 
                        <name>
                            <surname>Auclerc</surname>
                            <given-names>MF</given-names>
                        </name>, 
                        <name>
                            <surname>Rapion</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Bakkus</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Caye</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Khemiri</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <etal>et al</etal>.
                    </person-group>
                    <article-title>An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions</article-title>. 
                    <source>Leukemia</source>. 
                    <year>2014</year>
                    <month>Jan</month>;
                    <volume>28</volume>(
                    <issue>1</issue>):
                    <fpage>70</fpage>–
                    <lpage>7</lpage>. 
                    <pub-id pub-id-type="doi">10.1038/leu.2013.277</pub-id>
                    <pub-id pub-id-type="pmid">24064621</pub-id>
                    <issn>0887-6924</issn>
                </mixed-citation>
            </ref>
            <ref id="b14">
                <label>14.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Borowitz</surname>
                            <given-names>MJ</given-names>
                        </name>, 
                        <name>
                            <surname>Devidas</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Hunger</surname>
                            <given-names>SP</given-names>
                        </name>, 
                        <name>
                            <surname>Bowman</surname>
                            <given-names>WP</given-names>
                        </name>, 
                        <name>
                            <surname>Carroll</surname>
                            <given-names>AJ</given-names>
                        </name>, 
                        <name>
                            <surname>Carroll</surname>
                            <given-names>WL</given-names>
                        </name>, 
                        <etal>et al</etal>.; 
                        <collab>Children’s Oncology Group</collab>
                    </person-group>. 
                    <article-title>Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children’s Oncology Group study</article-title>. 
                    <source>Blood</source>. 
                    <year>2008</year>
                    <month>Jun</month>;
                    <volume>111</volume>(
                    <issue>12</issue>):
                    <fpage>5477</fpage>–
                    <lpage>85</lpage>. 
                    <pub-id pub-id-type="doi">10.1182/blood-2008-01-132837</pub-id>
                    <pub-id pub-id-type="pmid">18388178</pub-id>
                    <issn>0006-4971</issn>
                </mixed-citation>
            </ref>
            <ref id="b15">
                <label>15.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Möricke</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Zimmermann</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Reiter</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Henze</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Schrauder</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Gadner</surname>
                            <given-names>H</given-names>
                        </name>, 
                        <etal>et al</etal>.
                    </person-group>
                    <article-title>Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000</article-title>. 
                    <source>Leukemia</source>. 
                    <year>2010</year>
                    <month>Feb</month>;
                    <volume>24</volume>(
                    <issue>2</issue>):
                    <fpage>265</fpage>–
                    <lpage>84</lpage>. 
                    <pub-id pub-id-type="doi">10.1038/leu.2009.257</pub-id>
                    <pub-id pub-id-type="pmid">20010625</pub-id>
                    <issn>0887-6924</issn>
                </mixed-citation>
            </ref>
            <ref id="b16">
                <label>16.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Pui</surname>
                            <given-names>CH</given-names>
                        </name>, 
                        <name>
                            <surname>Pei</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <name>
                            <surname>Sandlund</surname>
                            <given-names>JT</given-names>
                        </name>, 
                        <name>
                            <surname>Ribeiro</surname>
                            <given-names>RC</given-names>
                        </name>, 
                        <name>
                            <surname>Rubnitz</surname>
                            <given-names>JE</given-names>
                        </name>, 
                        <name>
                            <surname>Raimondi</surname>
                            <given-names>SC</given-names>
                        </name>, 
                        <etal>et al</etal>.
                    </person-group>
                    <article-title>Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia</article-title>. 
                    <source>Leukemia</source>. 
                    <year>2010</year>
                    <month>Feb</month>;
                    <volume>24</volume>(
                    <issue>2</issue>):
                    <fpage>371</fpage>–
                    <lpage>82</lpage>. 
                    <pub-id pub-id-type="doi">10.1038/leu.2009.252</pub-id>
                    <pub-id pub-id-type="pmid">20010620</pub-id>
                    <issn>0887-6924</issn>
                </mixed-citation>
            </ref>
            <ref id="b17">
                <label>17.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Silverman</surname>
                            <given-names>LB</given-names>
                        </name>, 
                        <name>
                            <surname>Stevenson</surname>
                            <given-names>KE</given-names>
                        </name>, 
                        <name>
                            <surname>O’Brien</surname>
                            <given-names>JE</given-names>
                        </name>, 
                        <name>
                            <surname>Asselin</surname>
                            <given-names>BL</given-names>
                        </name>, 
                        <name>
                            <surname>Barr</surname>
                            <given-names>RD</given-names>
                        </name>, 
                        <name>
                            <surname>Clavell</surname>
                            <given-names>L</given-names>
                        </name>, 
                        <etal>et al</etal>.
                    </person-group>
                    <article-title>Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000)</article-title>. 
                    <source>Leukemia</source>. 
                    <year>2010</year>
                    <month>Feb</month>;
                    <volume>24</volume>(
                    <issue>2</issue>):
                    <fpage>320</fpage>–
                    <lpage>34</lpage>. 
                    <pub-id pub-id-type="doi">10.1038/leu.2009.253</pub-id>
                    <pub-id pub-id-type="pmid">20016537</pub-id>
                    <issn>0887-6924</issn>
                </mixed-citation>
            </ref>
            <ref id="b18">
                <label>18.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Hunger</surname>
                            <given-names>SP</given-names>
                        </name>, 
                        <name>
                            <surname>Loh</surname>
                            <given-names>ML</given-names>
                        </name>, 
                        <name>
                            <surname>Whitlock</surname>
                            <given-names>JA</given-names>
                        </name>, 
                        <name>
                            <surname>Winick</surname>
                            <given-names>NJ</given-names>
                        </name>, 
                        <name>
                            <surname>Carroll</surname>
                            <given-names>WL</given-names>
                        </name>, 
                        <name>
                            <surname>Devidas</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <etal>et al</etal>.; 
                        <collab>COG Acute Lymphoblastic Leukemia Committee</collab>
                    </person-group>. 
                    <article-title>Children’s Oncology Group’s 2013 blueprint for research: acute lymphoblastic leukemia</article-title>. 
                    <source>Pediatr Blood Cancer</source>. 
                    <year>2013</year>
                    <month>Jun</month>;
                    <volume>60</volume>(
                    <issue>6</issue>):
                    <fpage>957</fpage>–
                    <lpage>63</lpage>. 
                    <pub-id pub-id-type="doi">10.1002/pbc.24420</pub-id>
                    <pub-id pub-id-type="pmid">23255467</pub-id>
                    <issn>1545-5009</issn>
                </mixed-citation>
            </ref>
            <ref id="b19">
                <label>19.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Schmiegelow</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Forestier</surname>
                            <given-names>E</given-names>
                        </name>, 
                        <name>
                            <surname>Hellebostad</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Heyman</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Kristinsson</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Söderhäll</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <etal>et al</etal>.; 
                        <collab>Nordic Society of Paediatric Haematology and Oncology</collab>
                    </person-group>. 
                    <article-title>Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia</article-title>. 
                    <source>Leukemia</source>. 
                    <year>2010</year>
                    <month>Feb</month>;
                    <volume>24</volume>(
                    <issue>2</issue>):
                    <fpage>345</fpage>–
                    <lpage>54</lpage>. 
                    <pub-id pub-id-type="doi">10.1038/leu.2009.251</pub-id>
                    <pub-id pub-id-type="pmid">20010622</pub-id>
                    <issn>0887-6924</issn>
                </mixed-citation>
            </ref>
            <ref id="b20">
                <label>20.	</label>
                <mixed-citation publication-type="webpage">
                    <source>PDQ® Pediatric Treatment Editorial Board. PDQ Childhood Acute Lymphoblastic Leukemia Treatment</source>. 
                    <publisher_loc>Bethesda, MD</publisher_loc>: 
                    <publisher_name>National Cancer Institute</publisher_name>. 
                    <year>2018</year>. 
                    <date-in-citation content-type="access-date" iso-8601-date="2019-01-30">cited 2019 Jan 19</date-in-citation>
                    <comment>Available from</comment>: 
                    <ext-link ext-link-type="uri" xlink:href="https://www.cancer.gov/types/leukemia/hp/child-all-treatment-pdq">https://www.cancer.gov/types/leukemia/hp/child-all-treatment-pdq</ext-link> [citirano 4. januar 2019].
                </mixed-citation>
            </ref>
            <ref id="b21">
                <label>21. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Balduzzi</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Valsecchi</surname>
                            <given-names>MG</given-names>
                        </name>, 
                        <name>
                            <surname>Uderzo</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>De Lorenzo</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <name>
                            <surname>Klingebiel</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Peters</surname>
                            <given-names>C</given-names>
                        </name>
                    </person-group>.
                    <article-title>Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study</article-title>. 
                    <source>Lancet</source>. 
                    <year>2005</year>
                    <month>Aug</month>.
                    <volume>366</volume>(
                    <issue>9486</issue>):
                    <fpage>635</fpage>-
                    <lpage>42</lpage>.
                    <pub-id pub-id-type="doi">10.1016/S0140-6736(05)66998-X</pub-id>
                    <pub-id pub-id-type="pmid">16112299</pub-id>
                    <issn>0140-6736</issn>
                </mixed-citation>
            </ref>
            <ref id="b22">
                <label>22.	</label>
                <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Kuželički</surname>
                            <given-names>NK</given-names>
                        </name>, 
                        <name>
                            <surname>Šmid</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Raščan</surname>
                            <given-names>IM</given-names>
                        </name>, 
                        <name>
                            <surname>Jazbec</surname>
                            <given-names>J</given-names>
                        </name>
                    </person-group>. 
                    <article-title>6-MP based maintenance therapy of childhood ALL in Slovenia: a retrospective study from 1970 to 2004</article-title>.
                    <source>Zdrav Vestn</source>.
                    <year>2015</year>
                    <month>Apr</month>.
                    <volume>84</volume>(
                    <issue>2</issue>
                    <issn>1318-0347<issn>.
                </mixed-citation>
            </ref>
            <ref id="b23">
                <label>23. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Crews</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Lew</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Pei</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <name>
                            <surname>Cheng</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Bao</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Zheng</surname>
                            <given-names>J</given-names>
                        </name>
                    </person-group>.
                    <article-title>Genome-Wide Association Analyses Identify Susceptibility Loci For Vincristine-Induced Peripheral Neuropathy In Children With Acute Lymphoblastic Leukemia</article-title>. 
                    <source>Blood</source>. 
                    <year>2013</year> 
                    <month>Nov</month>.
                    <volume>122</volume>(
                    <issue>21<issue>):
                    <fpage>618</fpage>.
                    <issn>0006-4971</issn> 
                </mixed-citation>
            </ref>
            <ref id="b24">
                <label>24. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Hijiya</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Sluis</surname>
                            <given-names>IM</given-names>
                            <surname>van der</surname>
                        </name>
                    </person-group>. 
                    <article-title>Asparaginase-associated toxicity in children with acute lymphoblastic leukemia</article-title>.
                    <source>Leuk Lymphoma<source>. 
                    <year>2016</year>.
                    <volume>57<volume>(
                    <issue>4</issue>):
                    <fpage>748</fpage>-
                    <lpage>57</lpage>. 
                    <pub-id pub-id-type="doi">10.3109/10428194.2015.1101098</pub-id>
                    <pub-id pub-id-type="pmid">26457414</pub-id>
                    <issn>1042-8194</issn>
                </mixed-citation>
            </ref>
            <ref id="b25">
                <label>25.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Inaba</surname>
                            <given-names>H</given-names>
                        </name>, 
                        <name>
                            <surname>Pui</surname>
                            <given-names>CH</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Glucocorticoid use in acute lymphoblastic leukemia: comparison of prednisone and dexamethasone</article-title>. 
                    <source>Lancet Oncol</source>. 
                    <year>2010</year>
                    <month>Nov</month>;
                    <volume>11</volume>(
                    <issue>11</issue>):
                    <fpage>1096</fpage>–
                    <lpage>106</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/S1470-2045(10)70114-5</pub-id>
                    <pub-id pub-id-type="pmid">20947430</pub-id>
                    <issn>1470-2045</issn>
                </mixed-citation>
            </ref>
            <ref id="b26">
                <label>26.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Schmiegelow</surname>
                            <given-names>K</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Advances in individual prediction of methotrexate toxicity: a review</article-title>. 
                    <source>Br J Haematol</source>. 
                    <year>2009</year>
                    <month>Sep</month>;
                    <volume>146</volume>(
                    <issue>5</issue>):
                    <fpage>489</fpage>–
                    <lpage>503</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/j.1365-2141.2009.07765.x</pub-id>
                    <pub-id pub-id-type="pmid">19538530</pub-id>
                    <issn>0007-1048</issn>
                </mixed-citation>
            </ref>
            <ref id="b27">
                <label>27.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Schmiegelow</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Nielsen</surname>
                            <given-names>SN</given-names>
                        </name>, 
                        <name>
                            <surname>Frandsen</surname>
                            <given-names>TL</given-names>
                        </name>, 
                        <name>
                            <surname>Nersting</surname>
                            <given-names>J</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction</article-title>. 
                    <source>J Pediatr Hematol Oncol</source>. 
                    <year>2014</year>
                    <month>Oct</month>;
                    <volume>36</volume>(
                    <issue>7</issue>):
                    <fpage>503</fpage>–
                    <lpage>17</lpage>. 
                    <pub-id pub-id-type="doi">10.1097/MPH.0000000000000206</pub-id>
                    <pub-id pub-id-type="pmid">24936744</pub-id>
                    <issn>1077-4114</issn>
                </mixed-citation>
            </ref>
            <ref id="b28">
                <label>28.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Nachman</surname>
                            <given-names>JB</given-names>
                        </name>
                    </person-group>. 
                    <source>Osteonecrosis in childhood ALL<source>. 
                    <year>2011</year>.
                    <fpage>2298</fpage>-
                    <lpage>9</lpage>. 
                    <pub-id pub-id-type="doi">10.1182/blood-2011-01-324897</pub-id>
                    <pub-id pub-id-type="pmid">21350057</pub-id>
                        <issn>0006-4971</issn>
                </mixed-citation>
            </ref>
            <ref id="b29">
                <label>29. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Robison</surname>
                            <given-names>LL</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Late Effects of Acute Lymphoblastic Leukemia Therapy in Patients Diagnosed at 0-20 Years of Age</article-title>. 
                    <source>Hematology Am Soc Hematol Educ Program</source>.
                    <year>2011</year> 
                    <volume>2011</volume>(
                    <issue>1</issue>):
                    <fpage>238</fpage>-
                    <lpage>42</lpage>.
                    <pub-id pub-id-type="doi">10.1182/asheducation-2011.1.238</pub-id>
                    <pub-id pub-id-type="pmid">22160040</pub-id>
                    <issn>1520-4391</issn> 
                </mixed-citation>
            </ref>
            <ref id="b30">
                <label>30.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Lennard</surname>
                            <given-names>L</given-names>
                        </name>
                    </person-group>. 
                    <article-title>The clinical pharmacology of 6-mercaptopurine</article-title>. 
                    <source>Eur J Clin Pharmacol</source>. 
                    <year>1992</year>;
                    <volume>43</volume>(
                    <issue>4</issue>):
                    <fpage>329</fpage>–
                    <lpage>39</lpage>. 
                    <pub-id pub-id-type="doi">10.1007/BF02220605</pub-id>
                    <pub-id pub-id-type="pmid">1451710</pub-id>
                    <issn>0031-6970</issn>
                </mixed-citation>
            </ref>
            <ref id="b31">
                <label>31.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Karran</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <name>
                            <surname>Attard</surname>
                            <given-names>N</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer</article-title>. 
                    <source>Nat Rev Cancer</source>. 
                    <year>2008</year>
                    <month>Jan</month>;
                    <volume>8</volume>(
                    <issue>1</issue>):
                    <fpage>24</fpage>–
                    <lpage>36</lpage>. 
                    <pub-id pub-id-type="doi">10.1038/nrc2292</pub-id>
                    <pub-id pub-id-type="pmid">18097462</pub-id>
                    <issn>1474-175X</issn>
                </mixed-citation>
            </ref>
            <ref id="b32">
                <label>32.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Tiede</surname>
                            <given-names>I</given-names>
                        </name>, 
                        <name>
                            <surname>Fritz</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Strand</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Poppe</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <name>
                            <surname>Dvorsky</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Strand</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <etal>et al</etal>.
                    </person-group>
                    <article-title>CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes</article-title>. 
                    <source>J Clin Invest</source>. 
                    <year>2003</year>
                    <month>Apr</month>;
                    <volume>111</volume>(
                    <issue>8</issue>):
                    <fpage>1133</fpage>–
                    <lpage>45</lpage>. 
                    <pub-id pub-id-type="doi">10.1172/JCI16432</pub-id>
                    <pub-id pub-id-type="pmid">12697733</pub-id>
                    <issn>0021-9738</issn>
                </mixed-citation>
            </ref>
            <ref id="b33">
                <label>33.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Dervieux</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Brenner</surname>
                            <given-names>TL</given-names>
                        </name>, 
                        <name>
                            <surname>Hon</surname>
                            <given-names>YY</given-names>
                        </name>, 
                        <name>
                            <surname>Zhou</surname>
                            <given-names>Y</given-names>
                        </name>, 
                        <name>
                            <surname>Hancock</surname>
                            <given-names>ML</given-names>
                        </name>, 
                        <name>
                            <surname>Sandlund</surname>
                            <given-names>JT</given-names>
                        </name>
                    </person-group>.
                    <source>De novo purine synthesis inhibition and antileukemic effects of mercaptopurine alone or in combination with methotrexate in vivo<source>.
                    <year>2002</year>. 
                    <volume>100</volume>(
                    <issue>4</issue>): 
                    <fpage>1240</fpage>- 
                    <lpage>7</lpage>.
                    <pub-id pub-id-type="doi">10.1182/blood-2002-02-0495</pub-id>
                    <pub-id pub-id-type="pmid">12149204</pub-id>
                    <issn>0006-4971</issn>
                </mixed-citation>
            </ref>
            <ref id="b34">
                <label>34. </label>
                <mixed-citation publication-type="unknown">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Panetta</surname>
                            <given-names>JC</given-names>
                        </name>, 
                        <name>
                            <surname>Evans</surname>
                            <given-names>WE</given-names>
                        </name>, 
                        <name>
                            <surname>Cheok</surname>
                            <given-names>MH</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Mechanistic mathematical modelling of mercaptopurine effects on cell cycle of human acute lymphoblastic leukaemia cells</article-title>.
                    <source>Br J Cancer<source>. 16. januar 
                    <year>2006</year>
                    <month>Jan</month>.
                    <volume>94</volume>(
                    <issue>1</issue>):
                    <fpage>93</fpage>-
                    <lpage>100</lpage>. 
                    <pub-id pub-id-type="doi">10.1038/sj.bjc.6602893</pub-id>
                    <pub-id pub-id-type="pmid">16333308</pub-id>
                    <issn>0007-0920</issn>
                </mixed-citation>
            </ref>
            <ref id="b35">
                <label>35.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Weinshilboum</surname>
                            <given-names>R</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyltransferase</article-title>. 
                    <source>Drug Metab Dispos</source>. 
                    <year>2001</year>
                    <month>Apr</month>;
                    <volume>29</volume>(
                    <issue>4 Pt 2</issue>):
                    <fpage>601</fpage>–
                    <lpage>5</lpage>.
                    <pub-id pub-id-type="pmid">11259360</pub-id>
                    <issn>0090-9556</issn>
                </mixed-citation>
            </ref>
            <ref id="b36">
                <label>36.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Appell</surname>
                            <given-names>ML</given-names>
                        </name>, 
                        <name>
                            <surname>Berg</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Duley</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Evans</surname>
                            <given-names>WE</given-names>
                        </name>, 
                        <name>
                            <surname>Kennedy</surname>
                            <given-names>MA</given-names>
                        </name>, 
                        <name>
                            <surname>Lennard</surname>
                            <given-names>L</given-names>
                        </name>, 
                        <etal>et al</etal>.
                    </person-group>
                    <article-title>Nomenclature for alleles of the thiopurine methyltransferase gene</article-title>. 
                    <source>Pharmacogenet Genomics</source>. 
                    <year>2013</year>
                    <month>Apr</month>;
                    <volume>23</volume>(
                    <issue>4</issue>):
                    <fpage>242</fpage>–
                    <lpage>8</lpage>. 
                    <pub-id pub-id-type="doi">10.1097/FPC.0b013e32835f1cc0</pub-id>
                    <pub-id pub-id-type="pmid">23407052</pub-id>
                    <issn>1744-6872</issn>
                </mixed-citation>
            </ref>
            <ref id="b37">
                <label>37.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Milek</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Murn</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Jaksic</surname>
                            <given-names>Z</given-names>
                        </name>, 
                        <name>
                            <surname>Lukac Bajalo</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Jazbec</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Mlinaric Rascan</surname>
                            <given-names>I</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Thiopurine S-methyltransferase pharmacogenetics: genotype to phenotype correlation in the Slovenian population</article-title>. 
                    <source>Pharmacology</source>. 
                    <year>2006</year>;
                    <volume>77</volume>(
                    <issue>3</issue>):
                    <fpage>105</fpage>–
                    <lpage>14</lpage>. 
                    <pub-id pub-id-type="doi">10.1159/000093278</pub-id>
                    <pub-id pub-id-type="pmid">16691038</pub-id>
                    <issn>0031-7012</issn>
                </mixed-citation>
            </ref>
            <ref id="b38">
                <label>38.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Relling</surname>
                            <given-names>MV</given-names>
                        </name>, 
                        <name>
                            <surname>Schwab</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Whirl-Carrillo</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Suarez-Kurtz</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Pui</surname>
                            <given-names>CH</given-names>
                        </name>, 
                        <name>
                            <surname>Stein</surname>
                            <given-names>CM</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update</article-title>. 
                    <source>Clin Pharmacol Ther</source>. 
                    <year>2019</year>
                    <month>May</month>;
                    <volume>105</volume>(
                    <issue>5</issue>):
                    <fpage>1095</fpage>-
                    <lpage>1105</lpage>.
                    <pub-id pub-id-type="doi">10.1002/cpt.1304</pub-id>
                    <pub-id pub-id-type="pmid">30447069</pub-id> 
                    <issn>0009-9236</issn>
                </mixed-citation>
            </ref>
            <ref id="b39">
                <label>39. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Hindorf</surname>
                            <given-names>U</given-names>
                        </name>, 
                        <name>
                            <surname>Appell</surname>
                            <given-names>ML</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Genotyping should be considered the primary choice for pre-treatment evaluation of thiopurine methyltransferase function<article-title>. 
                    <source>J Crohns Colitis</source>. 
                    <year>2012</year>
                    <month>Jul</month>; 
                    <volume>6</volume>(
                    <issue>6</issue>):
                    <fpage>655</fpage>-
                    <lpage>9</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.crohns.2011.11.014</pub-id>
                    <pub-id pub-id-type="pmid">22398041</pub-id> 
                    <issn>1873-9946</issn>
                </mixed-citation>
            </ref>
            <ref id="b40">
                <label>40. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Ford</surname>
                            <given-names>L</given-names>
                        </name>, 
                        <name>
                            <surname>Kampanis</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <name>
                            <surname>Berg</surname>
                            <given-names>J.</given-names>
                        </name>
                    </person-group>.
                    <article-title>Thiopurine S-methyltransferase genotype-phenotype concordance: used as a quality assurance tool to help control the phenotype assay</article-title>.
                    <source>Ann Clin Biochem<source>. 
                    <year>2009</year>
                    <month>Mar</month>;
                    <volume>46</volume>(
                    <issue>2</issue>):
                    <fpage>152</fpage>-
                    <lpage>4</lpage>. 
                    <pub-id pub-id-type="doi">10.1258/acb.2008.008167</pub-id>
                    <pub-id pub-id-type="pmid">19164342</pub-id> 
                    <issn>0004-5632</issn>
                </mixed-citation>
            </ref>
            <ref id="b41">
                <label>41.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Chouchana</surname>
                            <given-names>L</given-names>
                        </name>, 
                        <name>
                            <surname>Narjoz</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Roche</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <name>
                            <surname>Golmard</surname>
                            <given-names>JL</given-names>
                        </name>, 
                        <name>
                            <surname>Pineau</surname>
                            <given-names>B</given-names>
                        </name>, 
                        <name>
                            <surname>Chatellier</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <etal>et al</etal>.
                    </person-group>
                    <article-title>Interindividual variability in TPMT enzyme activity: 10 years of experience with thiopurine pharmacogenetics and therapeutic drug monitoring</article-title>. 
                    <source>Pharmacogenomics</source>. 
                    <year>2014</year>
                    <month>Apr</month>;
                    <volume>15</volume>(
                    <issue>6</issue>):
                    <fpage>745</fpage>–
                    <lpage>57</lpage>. 
                    <pub-id pub-id-type="doi">10.2217/pgs.14.32</pub-id>
                    <pub-id pub-id-type="pmid">24897283</pub-id>
                    <issn>1462-2416</issn>
                </mixed-citation>
            </ref>
            <ref id="b42">
                <label>42. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Karas-Kuzelicki</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Smid</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Tamm</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Metspalu</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Mlinaric-Rascan</surname>
                            <given-names>I</given-names>
                        </name>
                    </person-group>. 
                    <article-title>From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity</article-title>. 
                    <source>Pharmacogenomics</source>. 
                    <year>2014</year>
                    <month>Aug</month>;
                    <volume>15</volume>(
                    <issue>15</issue>):
                    <fpage>1437</fpage>-
                    <lpage>49</lpage>. 
                    <pub-id pub-id-type="doi">10.2217/pgs.14.84</pub-id>
                    <pub-id pub-id-type="pmid">25303295</pub-id>
                    <issn>1462-2416</issn>
                </mixed-citation>
            </ref>
            <ref id="b43">
                <label>43. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Milek</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Karas Kuzelicki</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Smid</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Mlinaric-Rascan</surname>
                            <given-names>I.</given-names>
                        </name>
                    </person-group>.
                    <article-title>S-adenosylmethionine regulates thiopurine methyltransferase activity and decreases 6-mercaptopurine cytotoxicity in MOLT lymphoblasts</article-title>. 
                    <source>Biochem Pharmacol</source>. 
                    <year>2009</year>
                    <month>Jun</month>;
                    <volume>77</volume>(
                    <issue>12</issue>):
                    <fpage>1845</fpage>-
                    <lpage>53</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.bcp.2009.03.006</pub-id>
                    <pub-id pub-id-type="pmid">19428339</pub-id>
                    <issn>0006-2952</issn>
                </mixed-citation>
            </ref>
            <ref id="b44">
                <label>44. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Milek</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Smid</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Tamm</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Kuzelicki</surname>
                            <given-names>NK</given-names>
                        </name>, 
                        <name>
                            <surname>Metspalu</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Mlinaric-Rascan</surname>
                            <given-names>I</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Post-translational stabilization of thiopurine S-methyltransferase by S-adenosyl-L-methionine reveals regulation of TPMT*1 and *3C allozymes</article-title>. 
                    <source>Biochem Pharmacol</source>. 
                    <year>2012</year>
                    <month>Apr</month>;
                    <volume>83</volume>(
                    <issue>7</issue>):
                    <fpage>969<fpage>-
                    <lpage>76<lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.bcp.2012.01.010</pub-id>
                    <pub-id pub-id-type="pmid">22274639</pub-id>
                    <issn>0006-2952</issn>
                </mixed-citation>
            </ref>
            <ref id="b45">
                <label>45.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Karas-Kuzelicki</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Jazbec</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Milek</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Mlinaric-Rascan</surname>
                            <given-names>I</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Heterozygosity at the TPMT gene locus, augmented by mutated MTHFR gene, predisposes to 6-MP related toxicities in childhood ALL patients</article-title>. 
                    <source>Leukemia</source>. 
                    <year>2009</year>
                    <month>May</month>;
                    <volume>23</volume>(
                    <issue>5</issue>):
                    <fpage>971</fpage>–
                    <lpage>4</lpage>. 
                    <pub-id pub-id-type="doi">10.1038/leu.2008.317</pub-id>
                    <pub-id pub-id-type="pmid">18987660</pub-id>
                    <issn>0887-6924</issn>
                </mixed-citation>
            </ref>
            <ref id="b46">
                <label>46. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Dorababu</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <name>
                            <surname>Naushad</surname>
                            <given-names>SM</given-names>
                        </name>, 
                        <name>
                            <surname>Linga</surname>
                            <given-names>VG</given-names>
                        </name>, 
                        <name>
                            <surname>Gundeti</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Nagesh</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Kutala</surname>
                            <given-names>VK</given-names>
                        </name>
                    </person-group>.
                    <article-title>Genetic variants of thiopurine and folate metabolic pathways determine 6-MP-mediated hematological toxicity in childhood ALL</article-title>. 
                    <source>Pharmacogenomics</source>. 
                    <year>2012</year>
                    <month>Jul</month>;
                    <volume>13</volume>(
                    <issue>9</issue>):
                    <fpage>1001</fpage>-
                    <lpage>8</lpage>. 
                    <pub-id pub-id-type="doi">10.2217/pgs.12.70</pub-id>
                    <pub-id pub-id-type="pmid">22838948</pub-id>
                    <issn>1462-2416</issn>
                </mixed-citation>
            </ref>
            <ref id="b47">
                <label>47. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Smid</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Karas-Kuzelicki</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Jazbec</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Mlinaric-Rascan</surname>
                            <given-names>I.</given-names>
                        </name>
                    </person-group>.
                    <article-title>PACSIN2 polymorphism is associated with thiopurine-induced hematological toxicity in children with acute lymphoblastic leukaemia undergoing maintenance therapy</article-title>. 
                    <source>Sci Rep</source>. 
                    <year>2016</year>
                    <month>Jul</month>;(
                    <issue>6</issue>):
                    <fpage>30244</fpage>.
                    <pub-id pub-id-type="doi">10.1038/srep30244</pub-id>
                    <pub-id pub-id-type="pmid">27452984</pub-id>
                    <issn>2045-2322</issn> 
                </mixed-citation>
            </ref>
            <ref id="b48">
                <label>48.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Rutherford</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Daggett</surname>
                            <given-names>V</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Polymorphisms and disease: hotspots of inactivation in methyltransferases</article-title>. 
                    <source>Trends Biochem Sci</source>. 
                    <year>2010</year>
                    <month>Oct</month>;
                    <volume>35</volume>(
                    <issue>10</issue>):
                    <fpage>531</fpage>–
                    <lpage>8</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.tibs.2010.03.007</pub-id>
                    <pub-id pub-id-type="pmid">20382027</pub-id>
                    <issn>0968-0004</issn>
                </mixed-citation>
            </ref>
            <ref id="b49">
                <label>49.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Chiengthong</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Ittiwut</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Muensri</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Sophonphan</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Sosothikul</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <name>
                            <surname>Seksan</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <etal>et al</etal>.
                    </person-group>
                    <article-title>NUDT15 c.415C&gt;T increases risk of 6-mercaptopurine induced myelosuppression during maintenance therapy in children with acute lymphoblastic leukemia</article-title>. 
                    <source>Haematologica</source>. 
                    <year>2016</year>
                    <month>Jan</month>;
                    <volume>101</volume>(
                    <issue>1</issue>):
                    <fpage>e24</fpage>–
                    <lpage>6</lpage>. 
                    <pub-id pub-id-type="doi">10.3324/haematol.2015.134775</pub-id>
                    <pub-id pub-id-type="pmid">26405151</pub-id>
                    <issn>0390-6078</issn>
                </mixed-citation>
            </ref>
            <ref id="b50">
                <label>50.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Tanaka</surname>
                            <given-names>Y</given-names>
                        </name>, 
                        <name>
                            <surname>Kato</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Hasegawa</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <name>
                            <surname>Urayama</surname>
                            <given-names>KY</given-names>
                        </name>, 
                        <name>
                            <surname>Nakadate</surname>
                            <given-names>H</given-names>
                        </name>, 
                        <name>
                            <surname>Kondoh</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <etal>et al</etal>.
                    </person-group>
                    <article-title>Susceptibility to 6-MP toxicity conferred by a NUDT15 variant in Japanese children with acute lymphoblastic leukaemia</article-title>. 
                    <source>Br J Haematol</source>. 
                    <year>2015</year>
                    <month>Oct</month>;
                    <volume>171</volume>(
                    <issue>1</issue>):
                    <fpage>109</fpage>–
                    <lpage>15</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/bjh.13518</pub-id>
                    <pub-id pub-id-type="pmid">26033531</pub-id>
                    <issn>0007-1048</issn>
                </mixed-citation>
            </ref>
            <ref id="b51">
                <label>51. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Yang</surname>
                            <given-names>JJ</given-names>
                        </name>, 
                        <name>
                            <surname>Landier</surname>
                            <given-names>W</given-names>
                        </name>, 
                        <name>
                            <surname>Yang</surname>
                            <given-names>W</given-names>
                        </name>, 
                        <name>
                            <surname>Liu</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Hageman</surname>
                            <given-names>L</given-names>
                        </name>, 
                        <name>
                            <surname>Cheng</surname>
                            <given-names>C</given-names>
                        </name>
                    </person-group>.
                    <article-title>Inherited NUDT15 Variant Is a Genetic Determinant of Mercaptopurine Intolerance in Children With Acute Lymphoblastic Leukemia</article-title>. 
                    <source>J Clin Oncol</source>. 
                    <year>2015</year>
                    <month>Apr</month>.
                    <volume>33</volume>(
                    <issue>11</issue>):
                    <fpage>1235</fpage>-
                    <lpage>42</lpage>.
                    <pub-id pub-id-type="doi">10.1200/JCO.2014.59.4671</pub-id>
                    <pub-id pub-id-type="pmid">25624441</pub-id>
                    <issn>0732-183X</issn>
                </mixed-citation>
            </ref>
            <ref id="b52">
                <label>52. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Moriyama</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Yang</surname>
                            <given-names>Y-L</given-names>
                        </name>, 
                        <name>
                            <surname>Nishii</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Ariffin</surname>
                            <given-names>H</given-names>
                        </name>, 
                        <name>
                            <surname>Liu</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Lin</surname>
                            <given-names>T-N</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Novel variants in NUDT15 and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestry</article-title>. 
                    <source>Blood</source>. 
                    <year>2017</year>
                    <month>Sep</month>.
                    <volume>130</volume>(
                    <issue>10</issue>):
                    <fpage>1209</fpage>-
                    <lpage>12</lpage>.
                    <pub-id pub-id-type="doi">10.1182/blood-2017-05-782383</pub-id>
                    <pub-id pub-id-type="pmid">28659275</pub-id>
                    <issn>0006-4971</issn>
                </mixed-citation>
            </ref>
            <ref id="b53">
                <label>53. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Stocco</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Yang</surname>
                            <given-names>W</given-names>
                        </name>, 
                        <name>
                            <surname>Crews</surname>
                            <given-names>KR</given-names>
                        </name>, 
                        <name>
                            <surname>Thierfelder</surname>
                            <given-names>WE</given-names>
                        </name>, 
                        <name>
                            <surname>Decorti</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Londero</surname>
                            <given-names>M</given-names>
                        </name>
                    </person-group>. 
                    <article-title>PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity</article-title>. 
                    <source>Hum Mol Genet</source>. 
                    <year>2012</year>
                    <month>Nov</month>.
                    <volume>21</volume>(
                    <issue>21</issue>):
                    <fpage>4793</fpage>-
                    <lpage>804</lpage>.
                    <pub-id pub-id-type="doi">10.1093/hmg/dds302</pub-id>
                    <pub-id pub-id-type="pmid">22846425</pub-id>
                    <issn>0964-6906</issn>
                </mixed-citation>
            </ref>
            <ref id="b54">
                <label>54.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Stocco</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Cheok</surname>
                            <given-names>MH</given-names>
                        </name>, 
                        <name>
                            <surname>Crews</surname>
                            <given-names>KR</given-names>
                        </name>, 
                        <name>
                            <surname>Dervieux</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>French</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <name>
                            <surname>Pei</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <etal>et al</etal>.
                    </person-group>
                    <article-title>Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia</article-title>. 
                    <source>Clin Pharmacol Ther</source>. 
                    <year>2009</year>
                    <month>Feb</month>;
                    <volume>85</volume>(
                    <issue>2</issue>):
                    <fpage>164</fpage>–
                    <lpage>72</lpage>. 
                    <pub-id pub-id-type="doi">10.1038/clpt.2008.154</pub-id>
                    <pub-id pub-id-type="pmid">18685564</pub-id>
                    <issn>0009-9236</issn>
                </mixed-citation>
            </ref>
            <ref id="b55">
                <label>55.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Wan Rosalina</surname>
                            <given-names>WR</given-names>
                        </name>, 
                        <name>
                            <surname>Teh</surname>
                            <given-names>LK</given-names>
                        </name>, 
                        <name>
                            <surname>Mohamad</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Nasir</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Yusoff</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Baba</surname>
                            <given-names>AA</given-names>
                        </name>, 
                        <etal>et al</etal>.
                    </person-group>
                    <article-title>Polymorphism of ITPA 94C&gt;A and risk of adverse effects among patients with acute lymphoblastic leukaemia treated with 6-mercaptopurine</article-title>. 
                    <source>J Clin Pharm Ther</source>. 
                    <year>2012</year>
                    <month>Apr</month>;
                    <volume>37</volume>(
                    <issue>2</issue>):
                    <fpage>237</fpage>–
                    <lpage>41</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/j.1365-2710.2011.01272.x</pub-id>
                    <pub-id pub-id-type="pmid">21545474</pub-id>
                    <issn>0269-4727</issn>
                </mixed-citation>
            </ref>
            <ref id="b56">
                <label>56.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Smid</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Karas-Kuzelicki</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Milek</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Jazbec</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Mlinaric-Rascan</surname>
                            <given-names>I</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Association of ITPA genotype with event-free survival and relapse rates in children with acute lymphoblastic leukemia undergoing maintenance therapy</article-title>. 
                    <source>PLoS One</source>. 
                    <year>2014</year>
                    <month>Oct</month>;
                    <volume>9</volume>(
                    <issue>10</issue>):
                    <fpage>e109551</fpage>. 
                    <pub-id pub-id-type="doi">10.1371/journal.pone.0109551</pub-id>
                    <pub-id pub-id-type="pmid">25303517</pub-id>
                    <issn>1932-6203</issn>
                </mixed-citation>
            </ref>
            <ref id="b57">
                <label>57.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Huang</surname>
                            <given-names>L</given-names>
                        </name>, 
                        <name>
                            <surname>Tissing</surname>
                            <given-names>WJ</given-names>
                        </name>, 
                        <name>
                            <surname>de Jonge</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>van Zelst</surname>
                            <given-names>BD</given-names>
                        </name>, 
                        <name>
                            <surname>Pieters</surname>
                            <given-names>R</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Polymorphisms in folate-related genes: association with side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia</article-title>. 
                    <source>Leukemia</source>. 
                    <year>2008</year>
                    <month>Sep</month>;
                    <volume>22</volume>(
                    <issue>9</issue>):
                    <fpage>1798</fpage>–
                    <lpage>800</lpage>. 
                    <pub-id pub-id-type="doi">10.1038/leu.2008.66</pub-id>
                    <pub-id pub-id-type="pmid">18368069</pub-id>
                    <issn>0887-6924</issn>
                </mixed-citation>
            </ref>
            <ref id="b58">
                <label>58. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Radtke</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Zolk</surname>
                            <given-names>O</given-names>
                        </name>, 
                        <name>
                            <surname>Renner</surname>
                            <given-names>B</given-names>
                        </name>, 
                        <name>
                            <surname>Paulides</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Zimmermann</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Moricke</surname>
                            <given-names>A</given-names>
                        </name>
                    </person-group>.
                    <article-title>Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemia</article-title>. 
                    <source>Blood</source>. 
                    <year>2013</year>
                    <month>Jun</month>;
                    <volume>121</volume>(
                    <issue>26</issue>):
                    <fpage>5145</fpage>-
                    <fpage>53</fpage>. 
                    <pub-id pub-id-type="doi">10.1182/blood-2013-01-480335</pub-id>
                    <pub-id pub-id-type="pmid">23652803</pub-id>
                    <issn>0006-4971</issn>
                </mixed-citation>
            </ref>
            <ref id="b59">
                <label>59. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Erculj</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Kotnik</surname>
                            <given-names>BF</given-names>
                        </name>, 
                        <name>
                            <surname>Debeljak</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Jazbec</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Dolzan</surname>
                            <given-names>V</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Influence of folate pathway polymorphisms on high-dose methotrexate-related toxicity and survival in childhood acute lymphoblastic leukemia</article-title>.
                    <source>Leuk Lymphoma</source>. 
                    <year>2012</year>
                    <month>Jun</month>;
                    <volume>53</volume>(
                    <issue>6</issue>):
                    <fpage>1096</fpage>-
                    <fpage>104</fpage>. 
                    <pub-id pub-id-type="doi">10.3109/10428194.2011.639880</pub-id>
                    <pub-id pub-id-type="pmid">22074251</pub-id>
                    <issn>1042-8194</issn>
                </mixed-citation>
            </ref>
            <ref id="b60">
                <label>60.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Krajinovic</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Costea</surname>
                            <given-names>I</given-names>
                        </name>, 
                        <name>
                            <surname>Primeau</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Dulucq</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Moghrabi</surname>
                            <given-names>A</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Combining several polymorphisms of thymidylate synthase gene for pharmacogenetic analysis</article-title>. 
                    <source>Pharmacogenomics J</source>. 
                    <year>2005</year>;
                    <volume>5</volume>(
                    <issue>6</issue>):
                    <fpage>374</fpage>–
                    <lpage>80</lpage>. 
                    <pub-id pub-id-type="doi">10.1038/sj.tpj.6500332</pub-id>
                    <pub-id pub-id-type="pmid">16130010</pub-id>
                    <issn>1470-269X</issn>
                </mixed-citation>
            </ref>
            <ref id="b61">
                <label>61.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Lopez-Lopez</surname>
                            <given-names>E</given-names>
                        </name>, 
                        <name>
                            <surname>Martin-Guerrero</surname>
                            <given-names>I</given-names>
                        </name>, 
                        <name>
                            <surname>Ballesteros</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Garcia-Orad</surname>
                            <given-names>A</given-names>
                        </name>
                    </person-group>. 
                    <article-title>A systematic review and meta-analysis of 
                        <italic>MTHFR</italic> polymorphisms in methotrexate toxicity prediction in pediatric acute lymphoblastic leukemia
                    </article-title>. 
                    <source>Pharmacogenomics J</source>. 
                    <year>2013</year>
                    <month>Dec</month>;
                    <volume>13</volume>(
                    <issue>6</issue>):
                    <fpage>498</fpage>–
                    <lpage>506</lpage>. 
                    <pub-id pub-id-type="doi">10.1038/tpj.2012.44</pub-id>
                    <pub-id pub-id-type="pmid">23089671</pub-id>
                    <issn>1470-269X</issn>
                </mixed-citation>
            </ref>
            <ref id="b62">
                <label>62. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Umerez</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Gutierrez-Camino</surname>
                            <given-names>Á</given-names>
                        </name>, 
                        <name>
                            <surname>Muñoz-Maldonado</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Martin-Guerrero</surname>
                            <given-names>I</given-names>
                        </name>, 
                        <name>
                            <surname>Garcia-Orad</surname>
                            <given-names>A.</given-names>
                        </name>
                    </person-group>
                    <article-title>MTHFR polymorphisms in childhood acute lymphoblastic leukemia: influence on methotrexate therapy</article-title>. 
                    <source>Pharmacogenomics Pers Med</source>. 
                    <year>2017</year>
                    <month>Mar</month>;
                    <volume>10</volume>:
                    <fpage>69</fpage>-
                    <lpage>78</lpage>. 
                    <pub-id pub-id-type="doi">10.2147/PGPM.S107047</pub-id>
                    <pub-id pub-id-type="pmid">28392709</pub-id>
                    <issn>1178-7066</issn>
                </mixed-citation>
            </ref>
            <ref id="b63">
                <label>63. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Treviño</surname>
                            <given-names>LR</given-names>
                        </name>, 
                        <name>
                            <surname>Shimasaki</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Yang</surname>
                            <given-names>W</given-names>
                        </name>, 
                        <name>
                            <surname>Panetta</surname>
                            <given-names>JC</given-names>
                        </name>, 
                        <name>
                            <surname>Cheng</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Pei</surname>
                            <given-names>D</given-names>
                        </name>
                    </person-group>.
                    <article-title>Germline Genetic Variation in an Organic Anion Transporter Polypeptide Associated With Methotrexate Pharmacokinetics and Clinical Effects</article-title>. 
                    <source>J Clin Oncol</source>. 
                    <year>2009</year>
                    <month>Dec</month>.
                    <volume>27</volume>(
                    <issue>35</issue>:
                    <fpage>5972.8</fpage>-
                    <lpage>.10</lpage>.
                    <pub-id pub-id-type="doi">10.1200/JCO.2008.20.4156</pub-id>
                    <pub-id pub-id-type="pmid">19901119</pub-id>
                    <issn>0732-183X</issn>
                </mixed-citation>
            </ref>
            <ref id="b64">
                <label>64. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Ramsey</surname>
                            <given-names>LB</given-names>
                        </name>, 
                        <name>
                            <surname>Bruun</surname>
                            <given-names>GH</given-names>
                        </name>, 
                        <name>
                            <surname>Yang</surname>
                            <given-names>W</given-names>
                        </name>, 
                        <name>
                            <surname>Treviño</surname>
                            <given-names>LR</given-names>
                        </name>, 
                        <name>
                            <surname>Vattathil</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Scheet</surname>
                            <given-names>P</given-names>
                        </name>
                    </person-group>.
                    <article-title>Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition</article-title>. 
                    <source>Genome Res<source>.
                    <year>2012</year>
                    <month>Jan</month>;
                    <volume>22</volume>(
                    <issue>1</issue>):
                    <fpage>1</fpage>-
                    <lpage>8</lpage>. 
                    <pub-id pub-id-type="doi">10.1101/gr.129668.111</pub-id>
                    <pub-id pub-id-type="pmid">22147369</pub-id>
                    <issn>1088-9051</issn> 
               </mixed-citation>
            </ref>
            <ref id="b65">
                <label>65. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Liu</surname>
                            <given-names>S-G</given-names>
                        </name>, 
                        <name>
                            <surname>Gao</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Zhang</surname>
                            <given-names>R-D</given-names>
                        </name>, 
                        <name>
                            <surname>Zhao</surname>
                            <given-names>X-X</given-names>
                        </name>, 
                        <name>
                            <surname>Cui</surname>
                            <given-names>L</given-names>
                        </name>, 
                        <name>
                            <surname>Li</surname>
                            <given-names>W-J</given-names>
                        </name>
                    </person-group>.
                    <article-title>Polymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia</article-title>. 
                    <source>Oncotarget</source>. 
                    <year>2017</year>
                    <month>May</month>;
                    <volume>8</volume>(
                    <issue>23</issue>):
                    <fpage>37763</fpage>-
                    <lpage>72</lpage>.
                    <pub-id pub-id-type="doi">10.18632/oncotarget.17781</pub-id>
                    <pub-id pub-id-type="pmid">28525903</pub-id>
                    <issn>2852-5903</issn> 
                </mixed-citation>
            </ref>
            <ref id="b66">
                <label>66. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Zgheib</surname>
                            <given-names>NK</given-names>
                        </name>, 
                        <name>
                            <surname>Akra-Ismail</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Aridi</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Mahfouz</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Abboud</surname>
                            <given-names>MR</given-names>
                        </name>, 
                        <name>
                            <surname>Solh</surname>
                            <given-names>H</given-names>
                        </name>
                    </person-group>.
                    <article-title>Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia</article-title>. 
                    <source>Pharmacogenet Genomics</source>. 
                    <year>2014</year>
                    <month>Aug</month>;
                    <volume>24</volume>(
                    <issue>8</issue>):
                    <fpage>387</fpage>-
                    <lpage>96</lpage>. 
                    <pub-id pub-id-type="doi">10.1097/FPC.0000000000000069</pub-id>
                    <pub-id pub-id-type="pmid">25007187</pub-id>
                    <issn>1744-6872</issn> 
                </mixed-citation>
            </ref>
            <ref id="b67">
                <label>67. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Gervasini</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>de Murillo</surname>
                            <given-names>SG</given-names>
                        </name>, 
                        <name>
                            <surname>Jiménez</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>de la Maya</surname>
                            <given-names>MD</given-names>
                        </name>, 
                        <name>
                            <surname>Vagace</surname>
                            <given-names>JM</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Effect of polymorphisms in transporter genes on dosing, efficacy and toxicity of maintenance therapy in children with acute lymphoblastic leukemia</article-title>. 
                    <source>Gene</source>. 
                    <year>2017</year>
                    <month>Sep</month>;
                    <volume>628</volume>:
                    <fpage>72</fpage>-
                    <lpage>7</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.gene.2017.07.025</pub-id> 
                    <pub-id pub-id-type="pmid">28710036</pub-id>
                    <issn>0378-1119</issn> 
                </mixed-citation>
            </ref>
            <ref id="b68">
                <label>68.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Simon</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Marsot</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Villard</surname>
                            <given-names>E</given-names>
                        </name>, 
                        <name>
                            <surname>Choquet</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Khe</surname>
                            <given-names>HX</given-names>
                        </name>, 
                        <name>
                            <surname>Zahr</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <etal>et al</etal>.
                    </person-group>
                    <article-title>Impact of ABCC2 polymorphisms on high-dose methotrexate pharmacokinetics in patients with lymphoid malignancy</article-title>. 
                    <source>Pharmacogenomics J</source>. 
                    <year>2013</year>
                    <month>Dec</month>;
                    <volume>13</volume>(
                    <issue>6</issue>):
                    <fpage>507</fpage>–
                    <lpage>13</lpage>. 
                    <pub-id pub-id-type="doi">10.1038/tpj.2012.37</pub-id>
                    <pub-id pub-id-type="pmid">23069858</pub-id>
                    <issn>1470-269X</issn>
                </mixed-citation>
            </ref>
            <ref id="b69">
                <label>69.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Ansari</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Sauty</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Labuda</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Gagné</surname>
                            <given-names>V</given-names>
                        </name>, 
                        <name>
                            <surname>Rousseau</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Moghrabi</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <etal>et al</etal>.
                    </person-group>
                    <article-title>Polymorphism in multidrug resistance-associated protein gene 3 is associated with outcomes in childhood acute lymphoblastic leukemia</article-title>. 
                    <source>Pharmacogenomics J</source>. 
                    <year>2012</year>
                    <month>Oct</month>;
                    <volume>12</volume>(
                    <issue>5</issue>):
                    <fpage>386</fpage>–
                    <lpage>94</lpage>. 
                    <pub-id pub-id-type="doi">10.1038/tpj.2011.17</pub-id>
                    <pub-id pub-id-type="pmid">21606946</pub-id>
                    <issn>1470-269X</issn>
                </mixed-citation>
            </ref>
            <ref id="b70">
                <label>70. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Campbell</surname>
                            <given-names>JM</given-names>
                        </name>, 
                        <name>
                            <surname>Bateman</surname>
                            <given-names>E</given-names>
                        </name>, 
                        <name>
                            <surname>Stephenson</surname>
                            <given-names>MD</given-names>
                        </name>, 
                        <name>
                            <surname>Bowen</surname>
                            <given-names>JM</given-names>
                        </name>, 
                        <name>
                            <surname>Keefe</surname>
                            <given-names>DM</given-names>
                        </name>, 
                        <name>
                            <surname>Peters</surname>
                            <given-names>MDJ</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Methotrexate-induced toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses</article-title>. 
                    <source>Cancer Chemother Pharmacol</source>. 
                    <year>2016</year>
                    <month>Jul</month>;
                    <volume>78</volume>(
                    <issue>1</issue>):
                    <fpage>27</fpage>-
                    <fpage>39</fpage>. 
                    <pub-id pub-id-type="doi">10.1007/s00280-016-3043-5</pub-id>
                    <pub-id pub-id-type="pmid">27142726</pub-id>
                    <issn>0344-5704</issn> 
                </mixed-citation>
            </ref>
            <ref id="b71">
                <label>71.	</label>
                <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Fernandez</surname>
                            <given-names>CA</given-names>
                        </name>, 
                        <name>
                            <surname>Smith</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Yang</surname>
                            <given-names>W</given-names>
                        </name>, 
                        <name>
                            <surname>Daté</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Bashford</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <name>
                            <surname>Larsen</surname>
                            <given-names>E</given-names>
                        </name>
                    </person-group>. 
                    <article-title>HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies</article-title>.
                    <source>Blood</source>.
                    <year>2014</year>.
                    <fpage>1266</fpage>-
                    <lpage>76</lpage>.
                    <pub-id pub-id-type="doi">10.1182/blood-2014-03-563742</pub-id>
                    <pub-id pub-id-type="pmid">24970932</pub-id>
                    <issn>0006-4971</issn> 
                </mixed-citation>
            </ref>
            <ref id="b72">
                <label>72. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Chen</surname>
                            <given-names>SH</given-names>
                        </name>, 
                        <name>
                            <surname>Pei</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <name>
                            <surname>Yang</surname>
                            <given-names>W</given-names>
                        </name>, 
                        <name>
                            <surname>Cheng</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Jeha</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Cox</surname>
                            <given-names>NJ</given-names>
                        </name>
                    </person-group>.
                    <article-title>Genetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivity<article-title>. 
                    <source>Clin Pharmacol Ther</source>. 
                    <year>2010</year>
                    <month>Aug</month>; 
                    <volume>88</volume>(
                    <issue>2</issue>:
                    <fpage>191</fpage>-
                    <lpage>6</lpage>. 
                    <pub-id pub-id-type="doi">10.1038/clpt.2010.94</pub-id>
                    <pub-id pub-id-type="pmid">20592726</pub-id>
                    <issn>0009-9236</issn> 
                </mixed-citation>
            </ref>
            <ref id="b73">
                <label>73. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Relling</surname>
                            <given-names>MV</given-names>
                        </name>, 
                        <name>
                            <surname>Yang</surname>
                            <given-names>W</given-names>
                        </name>, 
                        <name>
                            <surname>Das</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Cook</surname>
                            <given-names>EH</given-names>
                        </name>, 
                        <name>
                            <surname>Rosner</surname>
                            <given-names>GL</given-names>
                        </name>, 
                        <name>
                            <surname>Neel</surname>
                            <given-names>M</given-names>
                        </name>
                    </person-group>.
                    <article-title>Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia</article-title>. 
                    <source>J Clin Oncol</source>. 
                    <year>2004</year>
                    <month>oct</month>;
                    <volume>22</volume>(
                    <issue>19</issue>):
                    <fpage>3930</fpage>-
                    <lpage>6</lpage>. 
                    <pub-id pub-id-type="doi">10.1200/JCO.2004.11.020</pub-id>
                    <pub-id pub-id-type="pmid">15459215</pub-id>
                    <issn>0732-183X</issn> 
                </mixed-citation>
            </ref>
            <ref id="b74">
                <label>74. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>French</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <name>
                            <surname>Hamilton</surname>
                            <given-names>LH</given-names>
                        </name>, 
                        <name>
                            <surname>Mattano</surname>
                            <given-names>LA</given-names>
                            <suffix>Jr</suffix>
                        </name>, 
                        <name>
                            <surname>Sather</surname>
                            <given-names>HN</given-names>
                        </name>, 
                        <name>
                            <surname>Devidas</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Nachman</surname>
                            <given-names>JB</given-names>
                        </name>
                    </person-group>.
                    <article-title>A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children’s Oncology Group<article-title>. 
                    <source>Blood</source>. 
                    <year>2008</year>
                    <month>May</month>;
                    <volume>111</volume>(
                    <issue>9</issue>):
                    <fpage>4496</fpage>-
                    <lpage>9</lpage>. 
                    <pub-id pub-id-type="doi">10.1182/blood-2007-11-123885</pub-id>
                    <pub-id pub-id-type="pmid">18285546</pub-id>
                    <issn>0006-4971</issn> 
                </mixed-citation>
            </ref>
            <ref id="b75">
                <label>75. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Kawedia</surname>
                            <given-names>JD</given-names>
                        </name>, 
                        <name>
                            <surname>Kaste</surname>
                            <given-names>SC</given-names>
                        </name>, 
                        <name>
                            <surname>Pei</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <name>
                            <surname>Panetta</surname>
                            <given-names>JC</given-names>
                        </name>, 
                        <name>
                            <surname>Cai</surname>
                            <given-names>X</given-names>
                        </name>, 
                        <name>
                            <surname>Cheng</surname>
                            <given-names>C</given-names>
                        </name>
                    </person-group>.
                    <article-title>Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia</article-title>. 
                    <source>Blood</source>. 
                    <year>2011</year>
                    <month>Feb</month>;
                    <volume>117</volume>(
                    <issue>8</issue>):
                    <fpage>2340</fpage>-
                    <lpage>7</lpage>. 
                    <pub-id pub-id-type="doi">10.1182/blood-2010-10-311969</pub-id>
                    <pub-id pub-id-type="pmid">21148812</pub-id>
                    <issn>0006-4971</issn> 
                </mixed-citation> 
            </ref>
            <ref id="b76">
                <label>76.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Whirl-Carrillo</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>McDonagh</surname>
                            <given-names>EM</given-names>
                        </name>, 
                        <name>
                            <surname>Hebert</surname>
                            <given-names>JM</given-names>
                        </name>, 
                        <name>
                            <surname>Gong</surname>
                            <given-names>L</given-names>
                        </name>, 
                        <name>
                            <surname>Sangkuhl</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Thorn</surname>
                            <given-names>CF</given-names>
                        </name>, 
                        <etal>et al</etal>.
                    </person-group>
                    <article-title>Pharmacogenomics knowledge for personalized medicine</article-title>. 
                    <source>Clin Pharmacol Ther</source>. 
                    <year>2012</year>
                    <month>Oct</month>;
                    <volume>92</volume>(
                    <issue>4</issue>):
                    <fpage>414</fpage>–
                    <lpage>7</lpage>. 
                    <pub-id pub-id-type="doi">10.1038/clpt.2012.96</pub-id>
                    <pub-id pub-id-type="pmid">22992668</pub-id> 
                    <issn>0009-9236</issn>
                </mixed-citation>
            </ref>
            <ref id="b77">
                <label>77.	</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Day</surname>
                            <given-names>M</given-names> 
                        </name>, 
                        <name>
                            <surname>Rutkowski</surname>
                            <given-names>JL</given-names>
                        </name>, 
                        <name>
                            <surname>Feuerstein</surname>
                            <given-names>GZ</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Translational medicine—a paradigm shift in modern drug discovery and development: the role of biomarkers</article-title>. 
                    <source>Adv Exp Med Biol</source>. 
                    <year>2009</year>;
                    <volume>655</volume>:
                    <fpage>1</fpage>–
                    <lpage>12</lpage>. 
                    <pub-id pub-id-type="doi">10.1007/978-1-4419-1132-2_1</pub-id>
                    <pub-id pub-id-type="pmid">20047030</pub-id>
                    <issn>0065-2598</issn>
                </mixed-citation>
            </ref>
        </ref-list>
    </back>
</article>